Potential conflict of interest: None reported.
Research Article
Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease†
Article first published online: 7 MAY 2009
DOI: 10.1002/mds.22619
Copyright © 2009 Movement Disorder Society
Additional Information
How to Cite
Simon, K. C., Chen, H., Gao, X., Schwarzschild, M. A. and Ascherio, A. (2009), Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov. Disord., 24: 1359–1365. doi: 10.1002/mds.22619
- †
Publication History
- Issue published online: 24 JUL 2009
- Article first published online: 7 MAY 2009
- Manuscript Accepted: 25 MAR 2009
- Manuscript Revised: 7 JAN 2009
- Manuscript Received: 1 OCT 2008
Funded by
- NIH/NINDS. Grant Numbers: R01 NS048517, T32 ES07069-26
- Intramural Research Program
- National Institute of Environmental Health Sciences
- National Institute of Health. Grant Numbers: Z01ES1019, W81XWH-091-0881
- Abstract
- Article
- References
- Cited By
Keywords:
- Parkinson's disease;
- estrogen;
- epidemiology;
- reproductive factors
Abstract
To determine if reproductive factors or exogenous estrogen are associated with risk of Parkinson's disease (PD), we conducted a prospective study with 22 years of follow-up among postmenopausal participants in the Nurses' Health Study. Relative risks (RRs) and 95% confidence intervals (CIs) of PD were estimated from a Cox proportional hazards model adjusting for potential confounders. Risk of PD was not significantly associated with any of the reproductive factors measured or exogenous estrogen use. Use of postmenopausal hormones, however, may modify the associations of smoking and caffeine intake with PD risk. The inverse relation between smoking and PD risk was attenuated among ever users of postmenopausal hormones (P for interaction = 0.05). Similar results were obtained for caffeine (P for interaction = 0.09). In exploratory analyses, women using progestin-only hormones were found to have an increased PD risk, but this result was based on a very small number of cases (n = 4). In this large longitudinal study, we found no evidence of a beneficial effect of exogenous or endogenous estrogens on risk of PD. The use of postmenopausal hormone use may interact with other risk factors, but findings are preliminary and need confirmation in other populations. © 2009 Movement Disorder Society

1531-8257/asset/MDS_left.gif?v=1&s=a99f3b698e6ae32e96dbc75c912d289e5c35649d)
1531-8257/asset/MDS_right.gif?v=1&s=4d3c8316b533aa4e41b7101a2d6fa6f082cf2505)
